It has been demonstrated to suppress CDK1 expression, control cell cycle, and limit proliferation in human ovarian cancer cells via the PI3K/Akt signaling pathway, leading to anti-ovarian cancer actions [47]. This evidence concerns the gene CDK1 and ovarian cancer.